C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 207/08 (2006.01) A61K 31/40 (2006.01) A61P 25/32 (2006.01)
Patent
CA 2713025
A selective kappa opioid receptor antagonist having the Formula (I) useful for treating ethanol use disorder withdrawal and anxiety, and/or depression, or schizophrenia as independent comorbid conditions.
Cette invention concerne un antagoniste sélectif des récepteurs d'opioïdes kappa de Formule (I), utile pour traiter le trouble, le sevrage et l'anxiété liés à la consommation d'éthanol, et/ou la dépression, ou la schizophrénie à titre d'affections co-morbides indépendantes.
Diaz Buezo Nuria
Mckinzie David Lee
Mitch Charles Howard
Pedregal-Tercero Concepcion
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Kappa selective opioid receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Kappa selective opioid receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Kappa selective opioid receptor antagonist will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1797706